0001415889-24-004475.txt : 20240220
0001415889-24-004475.hdr.sgml : 20240220
20240220185311
ACCESSION NUMBER: 0001415889-24-004475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaBrosse Nicole
CENTRAL INDEX KEY: 0001910662
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 24655685
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
form4-02202024_110227.xml
X0508
4
2024-02-16
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001910662
LaBrosse Nicole
C/O HALOZYME THERAPEUTICS, INC.
12390 EL CAMINO REAL
SAN DIEGO
CA
92130
false
true
false
false
SVP, CHIEF FINANCIAL OFFICER
0
Common Stock
2024-02-16
4
M
0
5093
0
A
15752
D
Common Stock
2024-02-16
4
F
0
2737
36.10
D
13015
D
Common Stock
2024-02-16
4
M
0
5329
0
A
18344
D
Common Stock
2024-02-16
4
F
0
2864
36.10
D
15480
D
Restricted Stock Units
0
2024-02-16
4
M
0
5093
0
D
Common Stock
5093
10186
D
Restricted Stock Units
0
2024-02-16
4
M
0
5329
0
D
Common Stock
5329
15987
D
The reported disposition of 2,737 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
The reported disposition of 2,864 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
/s/ James R. Oehler, Attorney-in-Fact
2024-02-20